Wedbush Securities Inc. grew its holdings in BlackRock Science and Technology Term Trust (NASDAQ:BSTZ – Free Report) by 30.3% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 856,178 shares of the company’s stock after acquiring an additional 199,091 shares during the period. BlackRock Science and Technology Term Trust accounts for approximately 0.7% of Wedbush Securities Inc.’s holdings, making the stock its 22nd largest position. Wedbush Securities Inc.’s holdings in BlackRock Science and Technology Term Trust were worth $27,620,000 at the end of the most recent quarter.
Several other hedge funds also recently modified their holdings of the business. US Bancorp DE raised its holdings in shares of BlackRock Science and Technology Term Trust by 165.3% during the 3rd quarter. US Bancorp DE now owns 1,804 shares of the company’s stock valued at $40,000 after purchasing an additional 1,124 shares in the last quarter. Geneos Wealth Management Inc. bought a new stake in BlackRock Science and Technology Term Trust in the first quarter worth $40,000. Fifth Third Bancorp bought a new stake in BlackRock Science and Technology Term Trust in the first quarter worth $57,000. Kestra Advisory Services LLC bought a new stake in BlackRock Science and Technology Term Trust in the fourth quarter worth $68,000. Finally, Advisory Services Network LLC acquired a new position in BlackRock Science and Technology Term Trust during the third quarter worth $147,000.
BlackRock Science and Technology Term Trust Stock Performance
NASDAQ BSTZ opened at $31.19 on Friday. BlackRock Science and Technology Term Trust has a fifty-two week low of $20.69 and a fifty-two week high of $31.89. The stock’s 50-day moving average is $29.53 and its two-hundred day moving average is $26.81.
BlackRock Science and Technology Term Trust Announces Dividend
BlackRock Science and Technology Term Trust Company Profile
BlackRock Science and Technology Term Trust (NASDAQ: BSTZ) is a closed-end management investment company that provides targeted exposure to companies engaged in the science and technology sectors. Listed on the NASDAQ stock exchange, the trust seeks to deliver total return composed of capital appreciation and monthly distributions over a defined term. It operates as a term trust, with an anticipated liquidation date in August 2028, at which point shareholders will receive proceeds based on the trust’s net asset value.
The trust’s investment strategy is centered on equity and equity-related securities of companies involved in advancing scientific research, technological innovation and related applications.
Read More
- Five stocks we like better than BlackRock Science and Technology Term Trust
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Want to see what other hedge funds are holding BSTZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Science and Technology Term Trust (NASDAQ:BSTZ – Free Report).
Receive News & Ratings for BlackRock Science and Technology Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Science and Technology Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
